Publication
Advancing digital health applications: priorities for innovation in real-world evidence generation
In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a ...
Publication
"An epidemiological model to estimate the prevalence of diffuse large B-cell lymphoma in the United States"
Background: Prevalence is reflective of disease incidence and survival, and defined as ...
Publication
Single-arm oncology trials and the nature of external controls arms
Aim: Single-arm trials with external control arms (ECAs) have gained popularity in ...
Publication
Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases
Introduction Previous studies have reported that more patients receive inhaled ...
Publication
Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real-world database
Purpose Describe patient characteristics and pregnancy outcomes among all pregnant ...
Publication
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
Importance There is limited evidence regarding whether the presence of serum antibodies ...
Publication
Glucose‐lowering medications and the risk of cancer: a methodological review of studies based on real‐world data
Aim To review the methodology of observational studies examining the association between ...
Publication
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology
No link
Publication
Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study
Background: Little data exists regarding the effectiveness and safety of rivaroxaban or ...
Publication
The role of real-world evidence in FDA-approved New Drug and Biologics License Applications
The US Food and Drug Administration (FDA) is open to accepting real-world evidence (RWE) ...
Publication
Real‐world evidence for assessing pharmaceutical treatments in the context of COVID‐19
The emergence and global spread of the severe acute respiratory syndrome coronavirus 2 ...
Publication
Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data
This retrospective observational study aimed to gain a better understanding of the ...
Publication
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses
Generating evidence from real-world data requires fit-for-purpose study design and data. ...
Publication
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021
In June 2020, preliminary results for the Randomised Evaluation of COVID-19 Therapy ...
Publication
Alternative Analytic and Matching Approaches for the Prevalent New-User Design: A Simulation Study
Purpose To describe the creation of prevalent new user (PNU) cohorts and compare the ...
Publication
Frequency of opioid dispensing after vaginal delivery
Objective: To describe nationwide patterns in outpatient opioid dispensing after vaginal ...
Publication
Accelerating AI with Synthetic Data
This book published by O'Reilly focuses on advancements in generating high-quality ...
Publication
Synthetic data as an enabler for machine learning applications in medicine
Publication
Validating A Membership Disclosure Metric For Synthetic Health Data
Publication
Measuring re-identification risk using a synthetic estimator to enable data sharing
Publication
Utility Metrics for Evaluating Synthetic Health Data Generation Methods: Validation Study
Publication
Evaluating the Utility of Synthetic COVID-19 Case Data
Publication
Can Synthetic Data Be A Proxy For Real Clinical Trial Data? A Validation Study
Publication